FLI1 and Ewing sarcoma: Immunotherapeutic approaches including antigen-presenting cell-based vaccines have been employed as single agent or as part of combination strategies having been substantiated by a report on immunogenicity of Ewing's sarcoma with specific translocation resulting in EWS/FLI1 fusion.